Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
Eliott Lafon, Michael Jäger, Angelika Bauer, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 4, pp. 1242-1252.e12
Open Access | Times Cited: 25

Showing 25 citing articles:

Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 444
T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia
Marianna Karachaliou, Gemma Moncunill, Ana Espinosa, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
Predictors of long-term neutralizing antibody titers following COVID-19 vaccination by three vaccine types: the BOOST study
Aric A. Prather, Ethan G. Dutcher, James E. Robinson, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technology
Harald Schöbel, Gabriel Diem, J Kiechl, et al.
Journal of Hospital Infection (2023) Vol. 135, pp. 11-17
Open Access | Times Cited: 15
Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses
Divya Sinha, Melyssa Yaugel-Novoa, Louis Waeckel, et al.
Antiviral Research (2024) Vol. 223, pp. 105823-105823
Closed Access | Times Cited: 5
SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response
Yuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 23
Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
Louisa Ruhl, Jenny F. Kühne, Kerstin Beushausen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort
Erika Zecca, Manuela Rizzi, Stelvio Tonello, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1766-1766
Open Access | Times Cited: 16
Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays
Ho‐Chang Kuo, Kuang-Che Kuo, Pin-Xian Du, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 4, pp. 100507-100507
Open Access | Times Cited: 8
Immunity of Heterologously and Homologously Boosted or Convalescent Individuals Against Omicron BA.1, BA.2, and BA.4/5 Variants
Michael Jäger, Gabriel Diem, Sabina Sahanic, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 160-168
Open Access | Times Cited: 5
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
Manuela Rizzi, Stelvio Tonello, Cristiana Brinno, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico
Erika Garay, Sean P. J. Whelan, Rebecca M. DuBois, et al.
Epidemiology and Infection (2024) Vol. 152
Open Access | Times Cited: 1
Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens
Chia-Lo Ho, Li-Chen Yen, Hongwei Huang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Neutralisation Resistance of SARS-CoV-2 Spike-Variants is Primarily Mediated by Synergistic Receptor Binding Domain Substitutions
Long V. Pham, Alexander P. Underwood, Alekxander Binderup, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern
Gabriel Diem, Eliott Lafon, Angelika Bauer, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 9
Open Access | Times Cited: 7
Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen
Michael Jäger, Stefanie Dichtl, Rosa Bellmann‐Weiler, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 4, pp. 528-532
Open Access | Times Cited: 6
Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections
Stefanie Dichtl, Viktoria Zaderer, Viktoria Kozubowski, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5
Gabriel Diem, Michael Jäger, Stefanie Dichtl, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 1
Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients
Astrid I. Knell, Anna-Katharina Böhm, Michael Jäger, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1756-1756
Open Access | Times Cited: 1
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
Gabriel Diem, Stefanie Dichtl, Viktoria Zaderer, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 1
Triple COVID-19 vaccination induces humoral and cellular immunity to SARS-CoV-2 with cross-recognition of the Omicron variant and IgA secretion
Louisa Ruhl, Jenny F. Kühne, Kerstin Beushausen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Authorea (Authorea) (2023)
Open Access
Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19
Stefan Holdenrieder, Carlos Eduardo dos Santos Ferreira, Jacques Izopet, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access
Page 1

Scroll to top